MUNIRA PORBANDERWALA: Open Payments
NPI 1275177040 · PELHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 13 payments from 7 companies in 2025. Trend: 2023 $201 · 2024 $586 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $167 |
| Tris Pharma Inc | 1 | $110 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: INGREZZA, Dyanavel XR, Auvelity, REXULTI, TRINTELLIX, ARISTADA, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across AL — which companies pay providers there.
